Table 1.
Clinical and pathological characteristics of patients by ACE-I/ARB administration
| No. ACE-I/ARB (%) | |||
|---|---|---|---|
| No | Yes | p Value | |
| Age: | 0.006 | ||
| Less than 65 | 87 (44.2) | 42 (29.4) | |
| Greater than 65 | 110 (55.8) | 101 (70.6) | |
| Gender: | 0.76 | ||
| M | 153 (77.7) | 113 (79) | |
| F | 44 (22.3) | 30 (21) | |
| Smoking: | 0.4 | ||
| Current | 37 (18.9) | 21 (14.7) | |
| Former | 104 (53.1) | 86 (60.1) | |
| Never | 55 (28.1) | 36 (25.2) | |
| Multifocality: | 0.67 | ||
| Yes | 80 (41) | 62 (43.4) | |
| No | 115 (59) | 81 (56.6) | |
| Intravesical chemotherapy: | 0.11 | ||
| Yes | 32 (16.2) | 33 (23.1) | |
| No | 165 (3.8) | 110 (76.9) | |
| BCG therapy: | 0.21 | ||
| Yes | 85 (43.1) | 52 (36.4) | |
| No | 112 (56.9) | 91 (63.3) | |
| Stage: | 0.05 | ||
| Ta | 130 (66) | 99 (69.2) | |
| T1 | 44 (22.3) | 38 (26.6) | |
| CIS | 23 (11.7) | 6 (4.2) | |
| Grade: | 0.51 | ||
| Low | 88 (47.7) | 69 (48.3) | |
| High | 109 (55.3) | 74 (51.7) | |
| Tumor size (cm): | 0.73 | ||
| Less than 3 | 115 (61.2) | 87 (63) | |
| Greater than 3 | 73 (38.8) | 51 (37) | |
| Muscle in specimen: | 0.48 | ||
| No | 134 (68) | 92 (64.3) | |
| Yes | 63 (32) | 51 (35.7) | |
| Second TUR: | 0.08 | ||
| No | 179 (90) | 121 (84.6) | |
| Yes | 18 (9.1) | 22 (15.4) | |
| Mitomycin C: | 0.01 | ||
| No | 180 (91.4) | 117 (81.8) | |
| Yes | 17 (8.6) | 26 (18.2) | |